20:16 , Feb 2, 2018 |  BC Week In Review  |  Financial News

Evonetix raises $12.3M series A

Synthetic biology company Evonetix Ltd. (Little Chesterford, U.K.) raised $12.3 million on Jan. 30 in a series A round co-led by new investors DCVC and Draper Esprit. New investor Morningside and existing investors Providence Investment,...
08:00 , Dec 15, 2008 |  BC Week In Review  |  Company News

Cambridge Consultants Inc., 3M deal

3M's 3M Drug Delivery Systems unit received an exclusive, worldwide license to develop and commercialize Cambridge's Conix Dry Powder Inhaler (DPI) technology. 3M will offer the technology to partners. Financial terms were not disclosed. Cambridge...
08:00 , Mar 4, 2002 |  BC Week In Review  |  Company News

Vectura Ltd., Arthur D. Little deal

Vectura acquired Arthur's Aspirair drug delivery technology and research team for $5 million. Cambridge Consultants, Arthur's European technology arm that developed Aspirair, will acquire an undisclosed stake in Vectura. Vectura Ltd. , Bath, U.K.  ...